That's a very good question, a few-million-dollar one.
The bottom line is that we have learned to work on a day-to-day basis. There are days when we don't get any technetium and cannot perform any tests. There are days when there is plenty of technetium, but it's not necessarily easy to call the patient and ask them to come for their test.
It's very painful not to be able to provide services to patients. All of us who are practising nuclear medicine got involved in the field because we felt it was a step forward in being able to diagnose diseases way before they were obvious on a CT or MR scanner. If you look at the sequence of diseases, they start at the genomic or genome level, and then at the end of the road a patient will have symptoms and you will see the cancer, for example, on a CT and MR. Nuclear medicine has the unique ability to be able to diagnose those diseases before they explode in a patient's body.
So our concern is that we cannot perform enough tests, and second that what we now see is referring physicians not sending their patients. So the diagnoses will be at a later stage and the cancers and cardiac disease will have progressed by then. So at the end of day, the patient is losing in all of this and society is losing because it's going to cost much more money.